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Overweight children have higher circulating hepcidin
concentrations and lower iron status but have dietary iron intakes
and bioavailability comparable with normal weight children
Abstract
BACKGROUND: Obesity increases the risk for iron deficiency, but the underlying mechanism is
unclear. It is possible that overweight individuals may have lower dietary iron intake and/or
bioavailability. Alternatively, obesity-related inflammation may increase hepcidin concentrations and
reduce iron availability. Circulating hepcidin levels have not been compared in normal weight vs
overweight individuals. OBJECTIVE: The objective of this study was to compare iron status, dietary
iron intake and bioavailability, as well as circulating levels of hepcidin, leptin and interleukin-6 (IL-6),
in overweight vs normal weight children. DESIGN: In 6-14-year-old normal and overweight children
(n=121), we measured dietary iron intake, estimated iron bioavailability and determined body mass
index s.d. scores (BMI-SDS). In all children (n=121), we measured fasting serum ferritin, soluble
transferrin receptor (sTfR), C-reactive protein (CRP) and leptin; in a subsample, we measured IL-6
(n=68) and serum hepcidin (n=30). RESULTS: There were no significant differences in dietary iron
intake or bioavailability comparing normal and overweight children. The prevalence of iron-deficient
erythropoiesis (an increased sTfR concentration) was significantly higher in the overweight than in the
normal weight children (20 vs 6%, P=0.022, with sTfR concentrations of 4.40+/-0.77 and 3.94+/-0.88
mg l(-1), respectively, P=0.010). Serum hepcidin levels were significantly higher in the overweight
children (P=0.001). BMI-SDS significantly correlated with sTfR (P=0.009), serum hepcidin (P=0.005)
and the three measures of subclinical inflammation, namely CRP (P<0.001), IL-6 (P<0.001) and leptin
(P<0.001). In a multiple regression model, serum hepcidin was correlated with BMI-SDS (P=0.020) and
body iron (P=0.029), but not with the inflammatory markers. CONCLUSION: Our findings indicate that
there is reduced iron availability for erythropoiesis in overweight children and that this is unlikely due to
low dietary iron supply but rather due to hepcidin-mediated reduced iron absorption and/or increased
iron sequestration.
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Background 
Obesity increases risk for iron deficiency, but the mechanism is unclear. It is possible 
that overweight individuals may have lower dietary iron intake and/or bioavailability. 
Alternatively, obesity-related inflammation may increase hepcidin concentrations and 
reduce iron availability. Circulating hepcidin levels have not been compared in normal 
weight vs. overweight individuals.  
Objective 
The objective was to compare iron status, dietary iron intake and bioavailability, as 
well as circulating levels of hepcidin, leptin and IL-6, in overweight vs. normal weight 
children.  
Design 
In 6 to 14 yr-old normal and overweight children (n=121), we measured dietary iron 
intake, estimated iron bioavailability, and determined body mass index standard 
deviation scores (BMI-SDS). In all children (n=121), we measured fasting serum 
ferritin (SF), transferrin receptor (sTfR), C-reactive protein (CRP), and leptin; in a 
subsample, we measured interleukin 6 (IL-6) (n=68) and serum hepcidin (n=30). . 
Results 
There were no significant differences in dietary iron intake or bioavailability 
comparing normal and overweight children. The prevalence of iron deficient 
erythopoesis (an increased sTfR concentration) was significantly higher in the 
overweight than in the normal weight children (20% vs. 6%, (p=0.022), with sTfR 
concentrations of 4.40 ± 0.77 and 3.94 ± 0.88 mg/l respectively (p=0.010)). Serum 
hepcidin levels were significantly higher in the overweight children (p=0.001). BMI-
SDS significantly correlated with sTfR (p=0.009), serum hepcidin (p=0.005) and the 
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three measures of subclinical inflammation: CRP (p=<0.001), IL-6 (p<0.001) and 
leptin (p<0.001). In a multiple regression model, serum hepcidin was correlated with 
BMI-SDS (p=0.020) and body iron (p=0.029), but not with the inflammatory markers. 
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Conclusion 
Our findings indicate there is reduced iron available for erythropoesis in overweight 
children and that this is unlikely due to low dietary iron supply but rather due to 
hepcidin-mediated reduced iron absorption and/or increased iron sequestration.  
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In industrialized countries, rates of iron deficiency are higher in overweight children 
and adults compared to their normal weight counterparts (1-9). The reason for this is 
unclear. Hepcidin is a 25 amino acid peptide hormone that plays a key role in body 
iron regulation. It is produced mainly by the liver, but also by adipose tissue (10, 11). 
Increased circulating hepcidin restricts intestinal iron absorption and macrophage 
iron release. Hepatic hepcidin expression is modulated in response to body iron 
stores, hypoxia, and inflammation, and low-grade inflammation is a characteristic of 
obesity. Proinflammatory cytokines, such as IL-6, effect hepcidin gene transcription 
via Janus kinase (JAK)/signal transducer and activator of transcription (STAT)3 
interactions (12, 13). Also, the adipokine leptin upregulates hepatic hepcidin 
expression through the JAK2/STAT3 signaling pathway (14). Thus, increased 
inflammation and/or leptin levels in obese individuals could reduce iron availability. In 
humans, higher body mass index predicts decreased iron absorption measured using 
stable isotopes, and also an impaired response to iron fortification (9, 14-16) 
 
It has also been suggested that reduced iron intake due to poor dietary choices by 
overweight individuals may contribute to poor iron status, but there is little data to 
support this (1, 9, 15, 16). In adults, dietary iron intake and its estimated 
bioavailability are similar in overweight and normal weight adults (17), but no data are 
available for children. Even if iron intakes and estimated dietary bioavailability are 
similar, absorption of dietary iron could be reduced in overweight individuals if 
circulating hepcidin is increased. To gain insight into the links between obesity and 
iron status, our study aim was to compare iron status, dietary iron intake and 
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bioavailability, as well as circulating levels of hepcidin, leptin and IL-6 in overweight 
vs. normal weight children.  
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Subjects and methods 
The subjects for this study were 6-14 yr-old children (n=121), living in the German 
speaking part of Switzerland. The children were a convenience sample recruited in 
two steps (first step n=68, second step n=53) mainly through letters to primary 
schools but, as recruitment of overweight children proved to be difficult, also to 
pediatricians. Data collection started in spring 2005 and was finished in fall 2007. At 
the primary schools all children interested in participating were invited and the 
children recruited through pediatricians were otherwise healthy overweight and 
obese children not yet enrolled in a weight loss program. Data on relationships 
between diet and metabolic factors from a subgroup of these children (n=79) has 
been published previously (18-21). Informed written consent was obtained from the 
parents and informed oral assent from the children. Ethical approval for the study 
was obtained from the ethics committee of the Swiss Federal Institute of Technology 
in Zürich. 
 
Dietary assessment was done using two 24-hr recalls and a 1-day weighed food 
record in the first group of children (n=68) and, in order to further improve data 
quality, two 24-hour recalls combined with one 3-day weighed food record in the 
second group of children (n=53). All interviews were done by well-trained female 
interviewers in the family home. Each family was visited twice by the same 
interviewer within three weeks. The 24-hour recalls were done at each visit and at the 
first visit, the interviewer gave instructions and guidelines for the weighed food 
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record. At the second visit, the weighed food record was carefully reviewed with the 
child and caretaker. Volumes and portion sizes for the 24-hour recalls were 
estimated using photographs of different portions of a variety of foods and meals. A 
combination of 24-hour recalls and a food record was used in order to provide a good 
overview of the children’s habitual diet; this approach has been validated in children 
as young as 8 yrs of age (22). An appointment was scheduled at the hospital clinic, 
at the parents’ convenience, usually within 1-2 weeks of the dietary assessment. 
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The children presented to the hospital clinic in the morning after a 12 hr overnight 
fast. Twelve ml of blood were taken by venipuncture. Height was measured to the 
nearest 0.5 cm and weight to the nearest 100 g using a digital balance (Beurer BF 
18, Ulm, Germany). Pubertal staging was done by presenting drawings of the 
different Tanner stages to the child and the parents.  
 
Data analysis 
Dietary data obtained from the three to five records were thoroughly checked and 
entered into a nutrition software system (EBISpro for Windows 6.0, Dr. J. Erhardt, 
University of Hohenheim, Germany). This system translates the amount of food eaten 
into individual nutrients and assigns consumed foods into 22 food groups. The 
program is based on the German Food and Nutrition Data Base BLS 2.3 (Federal 
Health Department, Berlin, Germany), and, for foods specific to Switzerland, 
incorporates values from the Swiss Food Composition Database (23). Energy and 
nutrient data were averaged across the three or five days to obtain a mean daily 
energy and nutrient intake for each child.  
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Total dietary iron intake was calculated by the program EBISpro, but for the 
determination of heme and non-heme iron all iron containing products were 
separately divided into animal tissue and other components. Percentages of heme 
iron in cooked animal products were estimated to be 60% for beef, 40% for pork, 
30% for chicken and 25% for fish (24). Heme iron bioavailability was assumed to be 
23% (25). Bioavailability of non-heme iron was calculated according to the equation 
of Monsen and Balintfy (26) which takes into account two enhancers of iron 
absorption, vitamin C and animal tissue. Enhancing factors (EF) were calculated as 
the sum of milligrams ascorbic acid plus the grams of cooked animal tissue. The 
further calculation of % iron bioavailability is meal based, but as the meal to meal 
variability in iron intake is modest (27), it was decided to use the mean daily non-
heme iron and EF intake of each child and to divide the value by 3 in order to achieve 
an approximate per meal intake. The following equations were then used to calculate 
non-heme iron bioavailability (26): 
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1. If Σ EF < 75: % bioavailability = 3 + 8.93 * ln (EF + 100 / 100) 
2. If Σ EF ≥ 75: % bioavailability = 8 
 
Body mass index (BMI) of the children was calculated as weight (kg) / height (m) 2. 
To scale the data for comparison across ages and sex, BMI standard deviation 
scores (BMI-SDS: individual BMI value – reference mean BMI value divided by SD) 
were calculated using the program Epi Info (Version 3.4.1) and the reference values 
proposed by the U.S. Centers for Disease Control and Prevention (CDC) in 2000. 
Age and gender specific criteria also from CDC (28) were used to classify children as 
normal weight or overweight (above the 85th percentile). These criteria have been 
previously validated in Swiss children at this age (29).  
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Laboratory analysis 
Serum was stored at -20°C until analysis: serum ferritin (SF) and C-reactive protein 
(CRP) were measured using chemiluminescent immunometry (Serum Ferritin / high 
sensitivity CRP, IMMULITE® Bühlmann Laboratories AG, Allschwil, Switzerland), 
soluble transferrin receptor (sTfR) by immunturbidimetry (sTfR, Cobas Integra, 
Roche, Basel, Switzerland), IL-6 and leptin using ELISA testkits (high sensitivity 
ELISA, Quantikine HS Human IL-6 Immunoassay, R&D Systems, Minneapolis, USA; 
Leptin (human) ELISA Kit, BioVender, Alexis Biochemicals, Lausen, Switzerland). In 
a sub sample of 30 subjects (9 normal weight, 6 overweight and 15 obese), where 
adequately stored serum was still available, serum hepcidin concentrations were 
determined at the Department of Clinical Chemistry of the Radboud University 
Nijmegen, The Netherlands (hepcidinanalysis.com), by a combination of weak cation 
exchange chromatography and time-of-flight mass spectrometry (30). The subsample 
did not differ from the complete sample with regard to age, BMI, iron status, dietary 
iron intake or inflammatory markers. Normal reference ranges are: sTfR 
concentration <5.0 mg/L (as indicated by the manufacturer) and SF concentrations of 
>15 μg/l (31). As sTfR concentrations measured by the above mentioned method are 
on average 30% lower as compared to the values by the ELISA assay from Ramco 
Laboratories (32) the values were corrected prior to the calculation of body iron 
stores as proposed by Cook et al. (33). For the correction of sTfR concentrations, the 
following formula was used: sTfR corr (Ramco) = (sTfR (Roche)-0.299)/0.631 (32). 
After correction, body iron stores were calculated as follows:  
body iron (mg/kg) = - [log(sTfR corr/SF) – 2.8229]/0.1207 (33). 
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Statistical analysis was performed using the statistical package SPSS 13.0 for 
Windows (SPSS Chicago, Illinois, USA). Non-normally distributed variables were log-
transformed for comparisons. Normally distributed data are presented as means ± 
SD and non-normally distributed data as medians (range). The data of three children 
were excluded prior to analysis: one child reported having had influenza and had an 
elevated CRP concentration (3.5 mg/l); in two other children (one in the normal 
weight and one in the overweight group) hepcidin concentrations were extreme 
outliers (>3 SD above the mean). Independent samples t-test was used to compare 
between the two weight categories and multiple regression models to study the effect 
of iron intake and bioavailability as well as obesity and inflammatory markers on iron 
status and the interactions between hepcidin, obesity, inflammation and iron status. 
All equations were checked for confounding factors like adiposity, age, puberty and 
gender and they were added as covariates if necessary. Fisher’s Exact test was used 
to compare proportions of iron deficient and non iron deficient subjects between 
normal weight and overweight subjects. 
 
Results 
Anthropometric characteristics, iron status parameters, markers of subclinical 
inflammation and iron intake, all by weight classification, are shown in Table 1. There 
was no significant difference in age between the two groups. Iron status, SF and 
body iron stores were not different between the groups, while sTfR was significantly 
higher in the overweight group (p=0.01). The prevalence of iron deficiency (based on 
the sTfR concentration) in the overweight and normal weight groups was 20% and 
6% (p<0.022). The three markers of subclinical inflammation (CRP, IL-6 and leptin) 
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increased with increasing adiposity (p<0.01). Hepcidin concentrations were 
significantly higher in the overweight children compared to the normal weight children 
(p=0.002).  
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The dietary variables are shown in Table 2. Total iron intakes did not differ 
significantly between groups. Heme iron intake and consumption of meat products 
were significantly higher in the overweight children compared to the normal weight 
children (p=0.006 and p=0.002, respectively). However, % bioavailability of non-
heme iron and total bioavailable iron did not differ significantly between the groups. 
There was a nonsignificant trend toward higher amounts of bioavailable iron in the 
overweight group (p=0.077). 
 
In a continuous, univariate analysis, BMI-SDS was significantly correlated with: 1) 
sTfR (r=0.240, p=0.009, see Figure 1); 2) serum hepcidin concentrations (r=0.527, 
p=0.005, see Figure 2) and 3) the three measures of subclinical inflammation, CRP 
(r=0.488, p=<0.001), IL-6 (r=0.434, p<0.001) and leptin (r=0.809, p<0.001). 
Moreover, BMI-SDS was correlated with heme iron intake (r=0.272, p=0.003) and the 
intake of meat products (r=0.269, p=0.003) as well as total bioavailable iron (r=0.192, 
p=0.037) but not to total iron intake. After controlling for BMI-SDS, SF was 
significantly correlated with CRP (r=0.311, p=0.001), but not with IL-6 or leptin. 
Serum hepcidin was correlated with body iron (r=0.467, p=0.014, see Figure 2), but 
not with any of the inflammatory markers.  
 
In a multiple regression model with sTfR as the dependent variable only BMI-SDS 
was a significant predictor (p=0.027, β=0.238); iron intake, iron bioavailability, age, 
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gender and pubertal stage were not significant predictors. In a multiple regression 
with serum hepcidin as the dependent variable, both BMI-SDS (p=0.020, β=0.680) 
and body iron (p=0.039, β=0.364) were significant predictors, but not the 
inflammatory markers CRP and leptin (n=28, adjusted r2=0.417). 
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Discussion 
Because obesity is associated with subclinical inflammation, and SF is an acute 
phase protein, sTfR is likely to be the best clinical measure of iron status in 
overweight individuals (16). In our data, adiposity was a predictor of poor iron status 
as measured by sTfR, but not SF. In iron deficiency, sTfR is increased because cell 
expression of the transferrin receptor is upregulated to increase uptake of circulating 
iron, primarily into marrow red cell precursors. sTfR concentrations are not 
significantly affected by inflammation, and are therefore useful in differentiating iron 
deficiency from inflammatory hypoferremia (34). Thus, in iron deficient overweight 
children, the sTfR and SF may be discrepant due to the confounding effect of 
obesity-associated inflammation on SF. In our children, all three inflammatory 
markers (CRP, IL-6 and leptin) significantly increased with increasing adiposity and 
CRP was a significant predictor of SF, but not TfR, independent of adiposity. Thus 
our data indicate poorer iron status in overweight compared to normal weight 
children, consistent with previous studies (1, 4-6, 9) and emphasize the limitations of 
SF as an iron status indicator in overweight individuals.  
 
It has been suggested that obesity may be associated with a low quality diet 
containing little iron (9). However, comparisons of dietary iron intake of normal and 
overweight adults (9, 17) and children (35) have found no significant differences in 
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total iron intake. However, in iron nutrition, total dietary iron is less important than the 
amount of bioavailable iron. In humans, dietary iron is consumed in two major forms: 
heme and non-heme iron. Because the bioavailability of these forms of dietary iron 
varies considerably, total dietary iron intake is not necessarily a good predictor of 
absorbed iron (36). Although in Western diets the intake of heme iron accounts only 
for around 10% of total dietary iron, it usually supplies most of the absorbed iron as it 
is relatively well absorbed (25-35%) (26, 37). Non-heme iron on the other hand 
accounts for about 90% of total dietary iron but its absorption is strongly influenced 
by dietary inhibitors and enhancers and usually is only 3 to 8%, depending on iron 
status (26). Although total dietary iron intake in the present study did not differ 
between weight groups, the intake of heme iron was significantly higher in the obese 
children due to their higher meat intake. Our findings agree with a recent adult study, 
where total iron consumption and iron bioavailability did not differ between obese and 
non obese subjects, while heme iron intake as well as the consumption of animal 
protein were higher in obese adults (17). 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
 
Calculating dietary iron bioavailability is challenging. Several algorithms are available 
for estimating bioavailability of non-heme dietary iron, based on intake of inhibiting 
and enhancing factors (25, 26, 38-41). In the present study we applied the algorithm 
by Monsen & Balintfy, which includes two enhancing factors, vitamin C and animal 
tissue, but no inhibiting factors (26). The major inhibitor of non-heme iron absorption, 
phytic acid, is included in several other algorithms (25, 38-40), but because reliable 
data on the phytic acid content of many foods consumed in Switzerland is not 
available, we were unable to use these algorithms. Despite this caveat, our data 
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suggest decreased dietary iron intake and/or bioavailability are an unlikely 
explanation for poorer iron status in overweight children. 
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In our study children, estimates of dietary iron intake and bioavailability did not vary 
with adiposity. However, the bioavailability of iron may be modulated not only by 
dietary factors but also by physiologic factors. Iron status, mediated by circulating 
hepcidin, is a primary determinant of dietary iron absorption. But hepatic hepcidin 
expression is modulated not only by body iron stores, but also hypoxia and 
inflammation. Proinflammatory cytokines, such as IL-6, as well as leptin, activate 
hepcidin gene transcription through a STAT3 binding motif at position –64/–72 of the 
promoter (12)  
 
The major new finding in this study is that circulating hepcidin concentrations are 
increased in overweight children, independent of iron status. Higher levels of 
hepcidin in overweight children may be due to obesity-related inflammation, and 
three inflammatory markers, CRP, IL-6 and leptin, were increased in the overweight 
children. However, we found no association of hepcidin with any of these 
inflammatory markers. But hepcidin is not only expressed in the liver but also at 
messenger RNA (mRNA) and protein levels in adipose tissue, and hepcidin mRNA 
expression is increased in adipose tissue of obese patients (10). Thus, it is possible 
that the increased hepcidin levels in our overweight children originated at least 
partially from adipose tissue rather than from inflammatory STAT3 activation of liver 
hepcidin expression.  
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Our findings confirm there is reduced iron available for erythropoesis in overweight 
children and that this is unlikely due to low dietary iron supply but rather due to 
hepcidin-mediated reduced iron absorption and/or increased iron sequestration. 
However, this hypothesis needs confirmation by intervention studies in overweight 
children that demonstrate weight loss reduces circulating hepcidin, increases iron 
absorption and improves iron status.  
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Table 1 Anthropometric characteristics, iron status and inflammatory markers of 6-14 
year old children living in Switzerland (n=118) 
1 
2 
 Normal weight 
(< 85th percentile) 
Overweight 
(≥ 85th percentile) 
n 33 85 
Male/female 13/20 43/42 
Age 10.0 ± 2.7 1,a 10.26 ± 1.84 a 
Weight (kg) 34.3 ± 9.2 a 53.0 ± 14.1 b 
Height (m) 1.43 ± 0.12 a 1.43 ± 0.11 a 
BMI (kg/m2) 16.6 ± 2.1 a 24.1 ± 3.8 b 
BMI-SDS -0.42 ± 1.07 a 1.76 ± 0.42 b 
Serum ferritin (ng/ml) 41.15 ± 24.5 a 45.3 ± 20.2a 
Transferrin receptor (mg/l) 3.94 ± 0.77 a 4.40 ± 0.88 b 
Body iron (mg/kg) 5.0 ± 2.6 a 5.2 ± 1.8 a 
Iron deficient based on an 
elevated sTfR;  no.(%) 
2 (6)  17 (20) 3 
Hepcidin (mM)5 1.4 (0.4-6.1) a 2.0 (1.2-5.4) b 
CRP (mg/l) 0.03 (0.01-0.42) 2,a 0.13 (0.03-2.25) b 
IL-6 (pg/ml) 6 0.25 (0.05-1.81) a 0.58 (0.10-2.10) b 
Leptin (ng/ml) 2.00 (0.11-24.16) a 18.72 (1.78-62.87) b 
1 mean ± SD, all such values 3 
4 
5 
6 
7 
8 
9 
10 
2 median (min. – max.) all such values 
Means or medians not sharing a common superscript letter are significantly different from 
each other at p<0.05 (independent samples t-test) 
3 Percentages do significantly differ between the normal weight and overweight subjects 
p=0.04 (Fisher’s Exact test for comparison of proportions) 
4The following correction was applied to calculate the body iron based on the sTfR: sTfR corr 
(Ramco) = (sTfR (Roche)-0.299)/0.631 (32) 
 19
5 Values from 28 subjects included only (9 normal weight, 6 overweight and 15 obese) 1 
2 6 Values measured in 68 subjects only 
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Table 2 Dietary iron intake and bioavailability of 6-14 year old children living in Switzerland 
(n=118) 
1 
2 
3  
 Normal weight 
(< 85th percentile) 
Overweight 
(≥ 85th percentile) 
n 33 85 
Total iron intake (mg) 10.0 ± 2.6 1,a 10.2 ± 2.8 a 
Heme iron intake (mg) 0.99 ± 0.90 a 1.48 ± 0.82 b 
Non-heme iron intake (mg) 9.11 ± 2.59 a 8.75 ± 2.75 a 
Vitamin C (mg) 104.5 ± 51.6 a 94.6 ± 49.8 a 
Meat products (g) 61.0 ± 42.2 a 90.1 ± 45.2 b 
Enhancing factors per meal 55.2 ± 22.6 a 61.6 ± 22.3 a 
% non-heme iron 
bioavailability 
6.7 ± 1.1 a 7.0 ± 1.1 a 
Bioavailable iron (mg) 0.84 ± 0.31 a  0.96 ± 0.30 a  
1 mean ± SD, all such values 4 
5 
6 
7 
Means not sharing a common superscript letter are significantly different from each other at 
p<0.05 (independent samples t-test) 
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Figure 1 Associations between BMI-SDS and soluble transferrin receptor in 6 to 14 year old 
children in Switzerland (n=118; r2=0.058) 
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Figure 2 Associations between log hepcidin and BMI-SDS as well as body iron in 6 to 14 
year old children in Switzerland (n=28; r2=0.278 and r2=0.218, respectively)  
 
 
 
